PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 26, 2026Clinical ChemistryOpen Access

Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJaniece GloverRHRomney Humphries

Discussion

Loading...

Member takes

Overview

Randomized trial shows enhanced patient outcomes through rapid antimicrobial susceptibility testing, suggesting improved clinical decision-making.

Key Points

  • This research examines the impact of rapid phenotypic susceptibility testing on antimicrobial resistance management and patient outcomes.
  • Implemented rapid phenotypic AST techniques in a clinical setting
  • Analyzed patient outcomes before and after the implementation of these techniques
  • Focused on evidence-based antimicrobial therapy in response to AST results.
  • Significant improvement in timely administration of effective antimicrobial therapy
  • Reduction in negative patient outcomes linked to delayed diagnosis
  • Enhanced clinical decision-making reported by healthcare professionals.

Cite This Study

Glover et al. (2026) studied this question.

synapsesocial.com/papers/69edabb84a46254e215b3a1fhttps://doi.org/10.1093/clinchem/hvag033
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria2025 · 12 citations
  2. 2Rapid Antimicrobial Susceptibility Testing (AST): Overview of New Commercially Available Automated Phenotypic Tools for Minimum Inhibitory Concentration (MIC) Determination2026 · 3 citations
  3. 3Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing2026
  4. 4Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype2024 · 10 citations
  5. 5P-1996. Performance Evaluation of an Artificial-Intelligence-Driven Single-Cell Imaging Platform for Rapid Phenotypic Antimicrobial Susceptibility Testing2026 · 1 citations